Health Technology Holding (HTH)

Health Technology Holding (HTH) is a venture capital firm, strategically investing across life sciences, biotech, medtech, and digital health sectors. The firm supports early to mid-stage companies developing innovative solutions to advance human health. HTH provides capital and strategic guidance, helping portfolio companies accelerate development and market penetration, fostering a robust health technology ecosystem.

Established in 2020, HTH originated from the ZCube-Zambon Research Venture, backed by the global pharmaceutical firm, Zambon Group. This foundation enabled HTH to leverage significant industry expertise. Michele Gaiotto serves as a key figure, leading investment decisions with insight into critical needs for specialized capital in health technology.

The firm’s primary engagement is with innovative companies developing novel therapies, advanced medical devices, and transformative digital health platforms. HTH empowers these ventures, fostering solutions addressing unmet medical needs. Its long-term vision centers on expanding an impactful investment portfolio, contributing to global healthcare evolution through targeted financial and operational backing.